Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-14 Sale |
2023-09-18 6:08 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,482 | $9.89 | $24,547 | 336,803 (Direct) |
View |
| 2023-08-22 Sale |
2023-08-24 6:05 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
1,807 | $9.47 | $17,112 | 340,566 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-15 6:09 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,322 | $9.99 | $23,197 | 349,746 (Direct) |
View |
| 2023-07-14 Sale |
2023-07-18 6:14 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,322 | $9.84 | $22,848 | 352,068 (Direct) |
View |
| 2023-06-14 Sale |
2023-06-16 6:14 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,322 | $10.69 | $24,822 | 354,390 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 6:08 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
1,790 | $11.13 | $19,923 | 352,833 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 6:17 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,322 | $11.26 | $26,146 | 367,172 (Direct) |
View |
| 2023-04-14 Sale |
2023-04-18 5:49 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $11.88 | $27,597 | 369,494 (Direct) |
View |
| 2023-03-14 Sale |
2023-03-16 7:04 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $10.32 | $23,973 | 371,817 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-13 5:57 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
4,000 | $10.2 | $40,800 | 360,190 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 7:34 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,323 | $10.05 | $23,346 | 374,140 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-20 Tax Withholding |
2023-08-22 6:19 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $9.7 | 1,704,336 (Direct) |
View |
| 2023-08-20 Tax Withholding |
2023-08-22 6:17 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
7,114 | $9.7 | 261,859 (Direct) |
View |
| 2023-08-20 Tax Withholding |
2023-08-22 6:15 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
8,912 | $9.7 | 285,297 (Direct) |
View |
| 2023-08-20 Tax Withholding |
2023-08-22 6:13 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
10,461 | $9.7 | 339,285 (Direct) |
View |
| 2023-08-20 Tax Withholding |
2023-08-22 6:10 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
10,460 | $9.7 | 342,373 (Direct) |
View |
| 2023-05-20 Tax Withholding |
2023-05-23 7:48 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $11.21 | 1,720,140 (Direct) |
View |
| 2023-05-20 Tax Withholding |
2023-05-23 7:46 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
8,744 | $11.21 | 268,973 (Direct) |
View |
| 2023-05-20 Tax Withholding |
2023-05-23 7:44 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
11,469 | $11.21 | 294,209 (Direct) |
View |
| 2023-05-20 Tax Withholding |
2023-05-23 7:41 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
10,460 | $11.21 | 356,712 (Direct) |
View |
| 2023-05-20 Tax Withholding |
2023-05-23 7:40 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
5,567 | $11.21 | 354,623 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:48 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | PAKIANATHAN DEEPIKA Director |
31,176 | $0 | 58,923 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:46 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | O'Connor Donal Director |
31,176 | $0 | 75,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:43 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | MITCHELL DEAN J Director |
31,176 | $0 | 92,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:41 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | MALKIEL BURTON G Director |
31,176 | $0 | 137,633 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:38 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | GRAY SUSANNAH Director |
31,176 | $0 | 42,995 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:36 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | BROSHY ERAN Director |
31,176 | $0 | 92,062 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 6:33 pm |
N/A 2033-05-01 |
Theravance Biopharma Inc. | TBPH | Smaldone Alsup Laurie Director |
31,176 | $0 | 75,838 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:41 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
330,000 | $0 | 1,735,944 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:38 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
80,000 | $0 | 277,717 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:35 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
75,000 | $0 | 304,958 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:32 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
75,000 | $0 | 376,463 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 8:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
75,000 | $0 | 364,190 (Direct) |
View |
| 2023-02-26 Option Award |
2023-02-28 8:17 pm |
N/A 2033-02-25 |
Theravance Biopharma Inc. | TBPH | GRAY SUSANNAH Director |
44,485 | $0 | 44,485 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
37,420 | $10.44 | 1,405,944 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:27 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER |
6,783 | $10.44 | 197,717 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:23 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY |
10,198 | $10.44 | 229,958 (Direct) |
View |
| 2023-02-20 Tax Withholding |
2023-02-22 7:21 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
12,057 | $10.44 | 301,463 (Direct) |
View |